Tags

Type your tag names separated by a space and hit enter

Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U.S.
Breast Cancer Res Treat. 2012 Apr; 132(2):683-91.BC

Abstract

No studies of dietary vitamin D intake and vitamin D receptor (VDR) have been conducted comparing breast risk among Hispanic women and non-Hispanic white (NHW) women. We investigated the association between vitamin D intake and breast cancer in a population-based case-control study of 1,527 NHW and 791 Hispanic breast cancer cases diagnosed in 1999-2004 in Arizona, New Mexico, Utah, and Colorado, and 1,599 NHW and 922 Hispanic age-matched controls. Vitamin D intake was assessed using food frequency questionnaires, and associations with breast cancer were adjusted for age, ethnicity, state, education, body mass index, smoking, age at menarche, age at first birth, parity, hormone exposure, height, and physical activity using logistic regression. BsmI, Poly A and FokI vitamin D receptor (VDR) genotypes were also measured. Dietary vitamin D intake was positively associated with breast cancer (highest vs. lowest quartile (Q (4) vs. Q (1)): odds ratio (OR) = 1.35, 95% confidence interval (CI) = 1.15-1.60; P (trend) = 0.003), whereas vitamin D supplement use was inversely associated with breast cancer (10+ μg/day vs. none: OR = 0.79, 95% CI = 0.65-0.96, P (trend) = 0.01). Similar patterns in risk were observed by ethnicity and menopausal status. Positive associations with dietary vitamin D intake and inverse associations with supplement use were observed for ER+/PR+ and ER-/PR- breast cancers, but not for ER+/PR- disease. BsmI genotype significantly modified the association between dietary vitamin D and breast cancer overall. Future research is needed to better understand potential differences in breast cancer risk by vitamin D source and hormone receptor status.

Authors+Show Affiliations

Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA. dana.rollison@moffitt.orgNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Multicenter Study
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

22130867

Citation

Rollison, Dana E., et al. "Vitamin D Intake, Vitamin D Receptor Polymorphisms, and Breast Cancer Risk Among Women Living in the Southwestern U.S." Breast Cancer Research and Treatment, vol. 132, no. 2, 2012, pp. 683-91.
Rollison DE, Cole AL, Tung KH, et al. Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U.S. Breast Cancer Res Treat. 2012;132(2):683-91.
Rollison, D. E., Cole, A. L., Tung, K. H., Slattery, M. L., Baumgartner, K. B., Byers, T., Wolff, R. K., & Giuliano, A. R. (2012). Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U.S. Breast Cancer Research and Treatment, 132(2), 683-91. https://doi.org/10.1007/s10549-011-1885-4
Rollison DE, et al. Vitamin D Intake, Vitamin D Receptor Polymorphisms, and Breast Cancer Risk Among Women Living in the Southwestern U.S. Breast Cancer Res Treat. 2012;132(2):683-91. PubMed PMID: 22130867.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U.S. AU - Rollison,Dana E, AU - Cole,Ashley L, AU - Tung,Ko-Hui, AU - Slattery,Martha L, AU - Baumgartner,Kathy B, AU - Byers,Tim, AU - Wolff,Roger K, AU - Giuliano,Anna R, Y1 - 2011/12/01/ PY - 2011/08/25/received PY - 2011/11/12/accepted PY - 2011/12/2/entrez PY - 2011/12/2/pubmed PY - 2012/6/23/medline SP - 683 EP - 91 JF - Breast cancer research and treatment JO - Breast Cancer Res. Treat. VL - 132 IS - 2 N2 - No studies of dietary vitamin D intake and vitamin D receptor (VDR) have been conducted comparing breast risk among Hispanic women and non-Hispanic white (NHW) women. We investigated the association between vitamin D intake and breast cancer in a population-based case-control study of 1,527 NHW and 791 Hispanic breast cancer cases diagnosed in 1999-2004 in Arizona, New Mexico, Utah, and Colorado, and 1,599 NHW and 922 Hispanic age-matched controls. Vitamin D intake was assessed using food frequency questionnaires, and associations with breast cancer were adjusted for age, ethnicity, state, education, body mass index, smoking, age at menarche, age at first birth, parity, hormone exposure, height, and physical activity using logistic regression. BsmI, Poly A and FokI vitamin D receptor (VDR) genotypes were also measured. Dietary vitamin D intake was positively associated with breast cancer (highest vs. lowest quartile (Q (4) vs. Q (1)): odds ratio (OR) = 1.35, 95% confidence interval (CI) = 1.15-1.60; P (trend) = 0.003), whereas vitamin D supplement use was inversely associated with breast cancer (10+ μg/day vs. none: OR = 0.79, 95% CI = 0.65-0.96, P (trend) = 0.01). Similar patterns in risk were observed by ethnicity and menopausal status. Positive associations with dietary vitamin D intake and inverse associations with supplement use were observed for ER+/PR+ and ER-/PR- breast cancers, but not for ER+/PR- disease. BsmI genotype significantly modified the association between dietary vitamin D and breast cancer overall. Future research is needed to better understand potential differences in breast cancer risk by vitamin D source and hormone receptor status. SN - 1573-7217 UR - https://www.unboundmedicine.com/medline/citation/22130867/Vitamin_D_intake_vitamin_D_receptor_polymorphisms_and_breast_cancer_risk_among_women_living_in_the_southwestern_U_S_ L2 - https://doi.org/10.1007/s10549-011-1885-4 DB - PRIME DP - Unbound Medicine ER -